Image of a hand with germs on it to show Roche COVID-19 test gets emergency FDA authorisation

FDA emergency authorisation for Roche’s COVID-19 test

Roche has announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its COVID-19 test, the cobas®...
Image of scientists standing around a giant magnifying glass with books, charts and research to show Elsevier gives full access to its coronavirus information centre content

Elsevier gives full access to its coronavirus information centre content

Elsevier is giving full access to its content on its coronavirus information centre for PubMed Central and other public health databases, such as the...
Image of raised blocks with lots of research and scientific items on to show Free scientific advice for coronavirus medicine or vaccine developers

Free scientific advice for coronavirus medicine or vaccine developers

The European Medicines Agency is offering free scientific advice to coronavirus medicine or vaccine developers. EMA is providing full fee waivers for scientific advice applications from...
Image of Pf Awards 2020 logo to indicate pf awards 2020 coronavirus update

Pf Awards 2020 coronavirus update 

It is with deepest regret that we have taken the decision to cancel the Pf Awards 2020. Please see our updated statement. With the Pf...
Image of six test tubes containing different coloured liquids to show Clover and GSK collaborate on coronavirus vaccine candidate

Clover and GSK collaborate on coronavirus vaccine candidate

Clover Biopharmaceuticals, a China based global clinical-stage biotechnology company focused on developing novel and transformative biologic therapies, announced that it has entered into a...

Latest articles

Entries for the Pf Awards 2022 are officially open

Enter today! The Pf Awards 2022 are officially open

New Year | New Suite of Categories | New Candidates Would you like to be recognised as a top performer in the UK Pharmaceutical industry? Enter...
MHRA licenses Gedeon Richter’s Ryeqo for symptoms of uterine fibroids  

MHRA licenses Gedeon Richter’s Ryeqo for symptoms of uterine fibroids  

The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted a licence for Ryeqo▼ (relugolix combination therapy), for the treatment of moderate to severe...
NICE issues draft guidance on dependence-forming medicines

NICE issues draft guidance on dependence-forming medicines  

The National Institute for Health and Care Excellence (NICE) has issued a new draft guideline on shared decision-making which looks at safe prescribing and...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Ground-breaking AI test could transform breast cancer diagnosis and treatment

Ground-breaking AI test could transform breast cancer diagnosis and treatment

Panakeia’s PANProfiler Breast assay - the world’s first AI software that can predict biomarker status from digitally imaged routine pathology samples - has received...
NICE issues draft guidance on dependence-forming medicines

NICE issues draft guidance on dependence-forming medicines  

The National Institute for Health and Care Excellence (NICE) has issued a new draft guideline on shared decision-making which looks at safe prescribing and...
pharmafield logo - pharma news

Top 5 R&D hubs in the UK

Read this cover story in the June issue of Pf Magazine here.    Join us on a tour of inspirational research and development centres. ...
MHRA licenses Gedeon Richter’s Ryeqo for symptoms of uterine fibroids  

MHRA licenses Gedeon Richter’s Ryeqo for symptoms of uterine fibroids  

The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted a licence for Ryeqo▼ (relugolix combination therapy), for the treatment of moderate to severe...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription